Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-05-18

FDA Approved: FENOFIBRATE — Supplemental Application (Bostal LLC)

View source ↗

Summary

FDA approved a supplemental application for Fenofibrate submitted by Bostal LLC under ANDA 207805. The approval confirms the continued approval of the generic p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FENOFIBRATE (Fenofibrate)

Snippet

SUPPL AP for FENOFIBRATE (FENOFIBRATE)